In the past five years, sustainability has evolved from a buzzword into a business imperative. Responsible sourcing in the life sciences sector has a direct impact not only on corporate ethics but also on public health outcomes. As clinical trials become more complex and multinational in scope, organizations are under increasing pressure to align with sustainable procurement practices and to do so transparently and measurably.